About OneWorld Health, PATH’s drug development program
Our Mission: Our mission is to develop and ensure availability and accessibility of safe and effective new medicines for diseases disproportionately affecting people in developing countries.
Who we are: We are scientists, medical researchers, doctors, and inspired individuals who are committed to changing the way we treat disease in the developing world. Headquartered in South San Francisco, we began as the first nonprofit pharmaceutical company in the United States. In 2011, OneWorld Health became a drug development affiliate of PATH. To learn more about PATH, visit www.path.org.
What we do: Our approach is simple: Assemble an experienced and dedicated team. Identify the most promising drug candidates. Develop them into safe, effective, and affordable medicines. Then collaborate with companies to manufacture and distribute newly approved therapies that will impact the health of millions.
We challenge the assumption that pharmaceutical research and development is too expensive to create the new medicines that the developing world desperately needs. By partnering and collaborating with industry and researchers, by securing donated intellectual property and finding new uses for orphan drugs, and harnessing the scientific and manufacturing capacity of both developed and developing countries, we can deliver safe, effective, and affordable new medicines where they are needed most.